INTRODUCTION
Neutrophils are the foot soldiers of the innate immune system as they are plentiful, short-lived, and armed with antimicrobial effector strategies. They are the first immune cells to arrive at a site of infection and are ready to respond, carrying presynthesized antimicrobial effectors and the enzymes needed to mount an intense burst of reactive oxygen species (ROS) (Amulic et al., 2012) . Antimicrobial effectors are synthesized during neutrophil development and are stored in specialized membrane-bound vesicles called granules. Granules contain different cargo depending on when they were synthesized. This results in a continuum of granule contents that are classified into four categories: secretory vesicles and azurophilic, specific, and gelatinase granules (Borregaard, 2010) .
Granule membranes are regarded as impermeable barriers that allow for delivery of their cargo through membrane fusion.
Neutrophils ingest and kill microbes intracellularly through phagocytosis. During this process, microbes are enclosed in a membrane compartment known as the phagosome, where exposure to ROS and antimicrobial effectors eliminates pathogens. The antimicrobial load of granules is delivered to the phagosome by fusion of the granule and phagosomal membranes. In addition, granules can fuse with the plasma membrane to release granule cargo extracellularly through degranulation.
In contrast to this classical view, an antimicrobial strategy that involves some unconventional cell biology was recently uncovered. Neutrophils were shown to release web-like structures known as neutrophil extracellular traps (NETs) that ensnare and kill a variety of microbes. NETs are composed of decondensed chromatin and a subset of granule and cytoplasmic proteins (Brinkmann et al., 2004) . Patients and animals carrying mutations in the genes required for NET formation are more susceptible to infections (Brinkmann and Zychlinsky, 2012) . On the other hand, unregulated NET release or lack of NET degradation is linked to several diseases, including cystic fibrosis, preeclampsia, autoimmunity, and vascular diseases (Garcia-Romo et al., 2011; Hakkim et al., 2010; Kessenbrock et al., 2009; Khandpur et al., 2013; Lande et al., 2011; Papayannopoulos et al., 2011; Villanueva et al., 2011) . Therefore, it is critical to understand the mechanisms that regulate NET formation.
NETs form in response to specific stimuli through a unique form of cell death called ''NETosis.'' The nuclear material expands while chromatin decondenses and the nuclear envelope disintegrates. The cytoplasmic membrane ruptures, liberating the NETs . A fraction of neutrophils have also been reported to release NETs without dying, leaving behind cytoplasts that continue to ingest microbes (Pilsczek et al., 2010; Yipp et al., 2012) .
A factor that is known to be critical for NET formation is neutrophil elastase (NE) . This serine protease is stored in azurophilic granules and contributes to antimicrobial activity in the phagosome. During NET formation, NE translocates from the granules to the nucleus and partially cleaves histones to promote chromatin decondensation . The mechanism of NE release from azurophilic granules remains unknown and does not involve membrane fusion.
ROS are crucial for effective antimicrobial responses. Patients with chronic granulomatous disease (CGD), who are deficient in NADPH oxidase activity, and individuals who are completely deficient in myeloperoxidase (DMPO; Figure S1A ) are susceptible to opportunistic infections, particularly to fungal pathogens (Nauseef, 2007) . Neutrophils from these patients fail to form NETs when stimulated with physiological NET stimuli such as fungi or the ROS agonist phorbol myristate acetate (PMA) .
Upon stimulation, neutrophils rapidly activate the NADPH oxidase to generate superoxide, a highly reactive molecule that dismutates to hydrogen peroxide (H 2 O 2 ) (Winterbourn and Kettle, 2013) . H 2 O 2 is consumed by MPO to produce hypochlorous acid (HOCl) and other oxidants. MPO is also required for NET formation, as shown in donors with complete MPO deficiency, but its role remains unclear . Although ROS are cytotoxic, they are also important signaling mediators that regulate protein function via the oxidation of specific amino acid residues (Nathan, 2003; Tonks, 2005; Winterbourn, 2008) . However, (A) Single confocal microscopy images of neutrophils from control, CGD, and DMPO donors. The neutrophils were stimulated for 60 min with C. albicans, immunolabeled for NE (red), and stained for DNA (Draq5, blue). Arrows indicate nuclear NE. Scale bars, 20 mm. (B) NE release into the cytosol during NETosis measured by ELISA in cytosolic extracts derived from naive neutrophils alone (N) or PMA-activated neutrophils (NP) from control and DMPO donors. NE in the cytosol normalized to the total amount of NE in the cytoplasmic extract of each sample at time 0. Error bars indicate SD in triplicate samples; ***p < 0.001 between control and DMPO samples at 60 min. Cytoplasmic extracts were made by nitrogen cavitation, without detergent, to keep the granule membranes intact. Cytosolic extracts were made by ultracentrifugation of cytoplasmic extracts. (C) Immunoblot of the degradation of exogenous histone H4 by cytoplasmic extract from naive neutrophils alone (N) or PMA-activated (NP) control and DMPO neutrophils. The cells were activated for the indicated time durations and H4 was incubated with the cytoplasmic extracts for 3 hr. (D) Immunoblot against endogenous histone H4 in total cell lysates of naive neutrophils alone (N) from control or DMPO donors. Naive neutrophils (N) or stimulated with PMA (NP) or C. albicans (NC) for the indicated durations in the presence (+NEi) or absence of NEi. Full-length (H4, arrow) and proteolytically processed H4 (H4*, red arrow). C, C. albicans alone. See also Figure S1 . since ROS are highly reactive, short-lived molecules, it is unclear how they are able to produce specific cellular responses. In particular, during NET formation, it is not known whether and how ROS regulate the selective translocation of NE from the granules to the nucleus. Furthermore, as the nucleus begins to decondense during NET formation, neutrophil chemotaxis is arrested through an unknown mechanism.
Using primary human neutrophils and proteins purified from healthy individuals and patient donors, we show that NE translocation involves a mechanism that does not require membrane fusion and regulates protease activation and actin dynamics.
RESULTS

ROS and MPO Are Required for NE Release from Granules
Since ROS production precedes NE translocation to the nucleus, we tested whether ROS and MPO are required for this process. In contrast to neutrophils from healthy ''control'' donors, in neutrophils derived from CGD and DMPO donors stimulated with Candida albicans (Figure 1A) or PMA ( Figure S1B ), NE failed to translocate to the nucleus and remained in granules.
We examined whether NE is first released from the granules into the cytosol. We stimulated neutrophils with PMA, lysed them at different time points, and isolated cytoplasm containing the soluble cytosol and granules. We obtained cytosol, which contains only the released soluble proteins, by ultracentrifugation of cytoplasm to remove granules, and monitored the presence of NE in these subcellular fractions by ELISA. NE was detected transiently in the cytosol of control neutrophils 60 min after activation ( Figure 1B) . Consistent with previous observations , NE disappeared from the cytosol 120 min after activation, as it translocated to the nucleus. In contrast, in DMPO neutrophils, NE was not detected in the cytosol.
NE proteolytic activity in the cytosol from naive and activated neutrophils was also detected by adding purified recombinant histone H4 to these fractions. H4 is the relevant NE substrate during NETosis. Background partial H4 cleavage was detected in cytosol from naive neutrophils, which may be due to cytosolic proteases. Notably, H4 was completely degraded when incubated with cytosol from control neutrophils stimulated with PMA for 30 min ( Figure 1C ). This is consistent with the presence of active NE in the cytosol, since we previously showed that this protease degrades soluble H4 processively . The peak of processive H4 degradation coincided with the highest cytosolic NE concentration detected by ELISA ( Figure 1C ). Recombinant H4 degradation was blocked by the small-molecule, cell-permeable NE inhibitor (NEi) GW311616A (Macdonald et al., 2001) , but not by an inhibitor of the related azurophilic granule protease, cathepsin G (CGi; Figure S1E ), indicating that H4 was degraded by active NE in the cytosol. In contrast, only background protease activity was detected in the cytosol of DMPO neutrophils, suggesting that MPO is required for the release of proteolytically active NE from the granules into the cytosol during NET formation.
Since the final destination of NE during NETosis is the nucleus, where it targets core histones, we examined the degradation of endogenous neutrophil nuclear H4 in activated control and DMPO neutrophils. Histone H4 was not cleaved in DMPO neutrophils stimulated with C. albicans ( Figure 1D ) or DMPO and CGD neutrophils stimulated with PMA ( Figures S1C and S1D) . Thus, ROS and MPO are required for the release of NE to the cytosol and its subsequent translocation to the nucleus during NETosis. Importantly, the route of NE translocation via the cytosol hinted that the translocation was driven by a novel MPO-dependent mechanism that does not involve membrane fusion.
We also examined whether this mechanism is implicated in the delivery of NE to the phagosome, which involves membrane fusion. Notably, NE cleaves bacterial virulence factors such as the Shigella flexneri IpaB protein inside the phagosome, preventing microbial escape from the phagosome (Weinrauch et al., 2002 ). Therefore, we tested whether MPO is required for NE function in the phagosome by incubating neutrophils with S. flexneri and examining the cleavage of the phagocytosed IpaB. IpaB was cleaved equally well by control neutrophils in the absence and presence of a pharmacological MPO inhibitor (ABAH; Figure S1F ). Furthermore, neutrophils derived from a DMPO donor degraded IpaB with comparable efficiency. As expected, IpaB degradation was prevented in control and DMPO neutrophils when NE activity was inhibited pharmacologically by NEi (Macdonald et al., 2001 ). Thus, this mechanism for NE release appears to be specific to NET formation and not phagocytosis.
Azurophilic Granules Contain the Machinery for NE Release Next, we investigated whether the factors that mediate NE release are contained in azurophilic granules. We isolated intact azurophilic granules by nitrogen cavitation and discontinuous Percoll density gradient centrifugation, which separates this granule subtype from other neutrophil granules and cytosol . To detect release of NE, we incubated granules with exogenous b-galactosidase and monitored its degradation by loss of b-galactosidase activity. To avoid variations in protease content between different granule preparations, we normalized the concentration of granules based on the content of NE and CG as measured by ELISA and immunoblotting. First, we tested whether H 2 O 2 was sufficient to trigger NE release in this system. Several lines of evidence suggest that H 2 O 2 , the substrate of MPO, is a key ROS intermediate in NET formation, since it is sufficient to stimulate NET formation in neutrophils and in a cell-free assay where neutrophil nuclei are incubated with cytoplasmic extracts containing azurophilic granules in vitro ( Figure S2A ; . Moreover, catalase, which consumes H 2 O 2 , blocks NET formation Parker et al., 2012) . Azurophilic granules from control donors degraded b-galactosidase upon treatment with H 2 O 2 , indicating that active proteases were released and gained access to the substrate in the absence of detergent (Figures 2A and S2B ). NEi and CGi together, but not individually, decreased b-galactosidase degradation, indicating the release of multiple active proteases ( Figure S2C ). Surprisingly, H 2 O 2 did not disrupt the overall integrity of the granules, as reflected by the conservation of the granule signature in a CASY impedance counter, which measures membrane integrity by the exclusion of electrical current ( Figure 2B ). This observation suggested that the mechanism of NE release does not involve the dissolution of granule membranes, but rather a novel means of release from intact granules. Moreover, H 2 O 2 failed to induce b-galactosidase degradation in DMPO granules, suggesting that MPO is required for NE release (Figures 2A and S2B) .
To examine whether H 2 O 2 plays a role in activating proteases in this assay independently of their release, we tested b-galactosidase degradation after dissolving granule membranes with detergent to expose the substrate to the proteases. In control granules, addition of detergent did not induce b-galactosidase degradation, but proteolytic activity required H 2 O 2 even in the absence of membranes (Figures 2A and S2B) . In contrast, H 2 O 2 treatment failed to activate proteases in DMPO granules treated with detergent. Therefore, the factors that drive protease activation and release in response to H 2 O 2 are localized in azurophilic granules, and MPO is critical for both processes.
Isolation and Identification of an Azurophilic Granule Complex
To identify the factors that mediate NE release and activation, we probed for NE-binding partners in azurophilic granules by immunoprecipitation. We isolated azurophilic granules from control neutrophils, solubilized them with detergent, and immunoprecipitated proteins with an antibody against NE or a control mock antibody against matrix metalloproteinase 9 (MMP9), a protein that is stored in gelatinase granules. Anti-NE, but not the control antibody, selectively coimmunoprecipitated a granule protein complex containing MPO, azurocidin (AZU), CG, eosinophil cationic protein (ECP), defensin-1 (HD1), lysozyme (LYZ), and lactoferrin (LTF) ( Figure 2C ). LTF is primarily a specific granule protein, but it has also been found in azurophilic granules . Western blot analysis confirmed the specific immunoprecipitation of several of these proteins (see Figures 4B-4D ). To further confirm the specificity of the immunoprecipitation, we immunoblotted against an azurophilic granule protein that was not immunoprecipitated. The bactericidal/permeability-increasing protein (BPI) was detected only upon immunoprecipitation with an antibody against BPI, and not with an anti-NE antibody ( Figure 2D ).
Interestingly, treatment of intact granules with H 2 O 2 prior to solubilization and immunoprecipitation led to the dissociation of this complex, as significantly less protein was coimmunopre- Figure S3B , pooled and concentrated). PR3, proteinase 3. See also Figure S2 . cipitated ( Figure 2C ). In order to investigate the effects of oxidation on the complex, we isolated azurophilic granules from peripheral blood neutrophils of healthy human donors and purified the complex by size-exclusion chromatography, probing the fractions for NE and MPO ( Figures S3A and S3B ). The complex eluted at a higher molecular weight than purified MPO ( Figure S3B ) and contained the same proteins that coprecipitated with NE as detected by mass spectrometry ( Figure 2E ). We also identified proteinase 3 (PR3), a related azurophilic granule protease with high homology to NE (Korkmaz et al., 2008) , in the purified complex. NE and MPO are present in the complex at a ratio of 2:1. Similarly to the immunoprecipitated complex ( Figure 2C ), the purified complex dissociated when pretreated with H 2 O 2 , as we did not detect these proteins in the complex-containing fractions by mass spectrometry, ELISA, or enzymatic activity ( Figures S3C-S3E ). This observation hinted that H 2 O 2 may regulate the function of this azurophilic granule complex by modulating the association of its components. To facilitate the nomenclature, we refer to this azurophilic granule complex as the ''azurosome.'' NE and MPO Localize to the Membrane in a Subset of Azurophilic Granules To investigate the localization of the complex in neutrophils, we labeled MPO and NE with immunogold and performed transmission electron microscopy. We found three subsets of granules in naive and activated neutrophils of control and MPO-deficient neutrophils. In one subset, NE and MPO localized to the granule membrane in a radial pattern ( Figure 3A , arrows). In the second subset of granules, NE and MPO were predominantly in the lumen ( Figure 3B ). In a third subpopulation, MPO and NE localized to both the membrane and the lumen (mixed). Our observations are consistent with similar findings in promyelocytes (Egesten et al., 1994) and confirm the heterogeneity of azurophilic granules (Borregaard, 2010) . Quantitation of electron micrographs showed that MPO and NE were localized exclusively in the membrane in 50% of labeled granules and exclusively in the lumen in 25%. In the remaining 25%, the proteins were localized in both the membrane and the lumen ( Figure 3C ). These data are consistent with the idea that azurosome components localize in the membrane in a subset of azurophilic granules, but they do not constitute a quantitative assessment of protein association and abundance.
To determine whether the azurosome is exposed on granule membranes, we incubated isolated native azurophilic granules with an antibody against MPO or a control antibody against BPI, a protein that is not found in the azurosome ( Figure 2D ) and is not expected to be on the membrane. We centrifuged the mixture of granules and antibodies over a discontinuous Percoll gradient and isolated the intact azurophilic granules from the appropriate gradient fraction. Only the antibody against MPO was detected in the azurophilic granule fraction, and the antibody against BPI did not cosediment, confirming that the granule membranes were intact and undamaged, shielding BPI from antibody recognition ( Figure 3D ). Neither of the two antibodies sedimented in the absence of granules. These results indicated that MPO is exposed on the surface of azurophilic granules and is accessible to antibodies added externally.
Consistently, treatment of azurophilic granules from naive control neutrophils with proteinase K in the absence of detergent partially degraded MPO and AZU, indicating that in naive neutrophils, a fraction of MPO and AZU are exposed at the surface of granules ( Figure 3E ). AZU was better protected than MPO, suggesting that the former may be less exposed. BPI was completely protected from degradation, corroborating that the granules were intact and the exposure of MPO and AZU was not due to damaged granule membranes. This was further confirmed by impedance measurement of membrane integrity (not shown).
Together, these data suggest that naive neutrophils contain a subset of azurophilic granules that harbor the azurosome on their membranes and are poised to release proteases upon oxidative stimulation. The association with membranes does not seem to require MPO, since NE localizes to granule membranes in both control and DMPO neutrophils ( Figure 3A) . Rather, MPO is required for the ability of the complex to release proteins across membranes. Figure 2C suggested that oxidants may regulate NE release from the granule by modulating the newly identified membrane-associated complex. To address whether H 2 O 2 is required for NE release during NETosis in neutrophils, we tested whether depleting intracellular H 2 O 2 with PEG-catalase, which is taken up by the cells and consumes H 2 O 2 , would block NE release into the cytosol. PEG-catalase completely blocked NE release, indicating that H 2 O 2 regulates this process and is required for NETosis ( Figure 4A ). Next, we investigated how H 2 O 2 triggers NE release. We previously found that during NETosis, NE translocates to the nucleus while MPO remains in the granules . The association of NE with MPO in granules of naive neutrophils suggested that H 2 O 2 stimulation may trigger their dissociation. Indeed, by immunoprecipitating the azurosome with an anti-NE antibody and immunoblotting, we found that in azurophilic granules treated with H 2 O 2 , MPO dissociated from NE ( Figure 4B ). Importantly, MPO dissociation did not require NE activity, since it was not blocked by a cocktail of protease inhibitors (PIs) against NE, CG, and other proteases ( Figure 4B ). The disappearance of immunoprecipitated MPO was not due to degradation or lack of recognition by the anti-MPO antibody, since MPO was detected in the lysate prior to immunoprecipitation in all samples. In addition, MPO dissociated from NE when the enzymatic activity of MPO was blocked pharmacologically with ABAH. Since ABAH does not completely suppress MPO activity ( Figure S4A ), we tested the ability of HOCl, the main product of MPO in these reactions, to drive complex dissociation. NE and MPO remained bound upon treatment of azurophilic granules with HOCl ( Figure S4B ), indicating that H 2 O 2 likely is sufficient to drive dissociation. However, one cannot rule out the possibility that dissociation is driven by other MPO oxidative products.
We also examined the dissociation of other azurosome proteins after treatment of azurophilic granules with H 2 O 2 and found that NE dissociates from MPO and LYZ, but remains bound to CG and AZU ( Figure 4C ). These data further confirm that the loss of MPO is due to dissociation from the complex, and not to inefficient immunoprecipitation, as these other proteases are pulled down with comparable efficiency. Consistent with these in vitro observations, we found a similar molecular pattern for release in activated neutrophils isolated from human control donors, where a complex of NE, CG, and AZU, but not MPO, coimmunoprecipitated from the cytosol at 60 min poststimulation ( Figure 4D ). Moreover, NE and CG translocated to the nucleus simultaneously in neutrophils activated with PMA ( Figure 4E ) or C. albicans ( Figure S4C ). In contrast, MPO and PR3 remained in granules during this early phase of NET formation . Therefore, during NET formation, H 2 O 2 triggers the dissociation of the complex with MPO remaining in the granules and a protease subcomplex selectively released into the cytoplasm.
The Azurosome Mediates MPO-Dependent Protein Release from Intact Granules
To address the role of MPO in NE release, we tested the ability of purified complex from healthy control and DMPO human donors to release the contents of calcein-loaded synthetic liposomes in the absence of other membrane proteins. Inside liposomes, calcein is packed at high concentrations that quench its fluorescence. Calcein release alleviates quenching, causing an increase in calcein fluorescence.
Incubating the calcein-loaded liposomes with a purified control complex resulted in calcein release in a dose-dependent manner ( Figure 5A ). The data fitted to a sigmoidal dose-response (D) Azurophilic granules incubated with rabbit IgG against MPO or BPI, fractionated by centrifugation over a discontinuous Percoll gradient of 1.05, 1.09, and 1.12 g/ml density. The soluble (S) top layer and the 1.09/1.12 interface that contains the intact azurophilic granules were collected to detect primary antibodies by SDS-PAGE electrophoresis and western immunoblotting with anti-rabbit IgG. Arrows point to MPO antibody that cofractionates with azurophilic granules. (E) Intact azurophilic granules from naive neutrophils alone or treated with proteinase K (0, 1, 10, and 100 mg/ml) and immunoblotted for MPO, AZU, and BPI. Arrow indicates the cleavage product of AZU.
curve with an apparent cooperativity Hill coefficient of 2.78, suggesting that approximately three complex molecules assemble on the membrane to mediate calcein release. Notably, azurosome isolated from control human donors released calcein approximately 40-fold more efficiently than azurosome isolated from a DMPO donor, indicating that MPO is critical for the release activity. Indeed, unlike azurocidin or NE (data not shown), purified MPO was sufficient to release calcein, albeit with 100-fold lower efficiency than the azurosome ( Figure 5B ). Preboiling the complex completely abrogated calcein release, indicating that the activity is mediated by proteins and not by residual detergent micelles ( Figure 5A ). The flowthrough from the azurosome purification did not induce release. We obtained similar calcein release curves with a control complex purified from azurophilic granules that were freeze-thawed and sonicated in the absence of detergent ( Figure S5A ). Impedance measurements confirmed that unlike the detergent control, the azurosome did not lyse liposomes ( Figure 5C ), indicating that it promotes release without rupturing or dissolving membranes. Adding purified MPO to the DMPO complex did not restore calcein release ( Figure S5B ), suggesting that a functional azurosome requires a particular assembly.
To examine whether the control azurosome was sufficient to mediate protein cargo release across native granule membranes, we incubated the complex with isolated specific and gelatinase native granules, which do not contain the complex, and monitored the release of LYZ from these granules into the soluble fraction after separation by ultracentrifugation ( Figure 5D ). The control azurosome mediated the release of significant levels of LYZ from native granules as compared with the low levels of the LYZ originating from the added control complex. In contrast, no LYZ was released by the DMPO complex, indicating that MPO is critical for the ability of the complex to translocate proteins across intact membranes. H 2 O 2 activates the proteolytic activity of granule proteases in an MPO-dependent manner (Figure 2A) . By testing fractions containing the purified azurosome, we found that the complex was sufficient to trigger protease activation (''posttreated,'' Figure S3F ). Interestingly, treatment with H 2 O 2 or NEi did not affect calcein release ( Figure S5C ), suggesting that translocation is not regulated by oxidation, at least in vitro. In contrast, NE and AZU release from native azurophilic granules was dependent on H 2 O 2 stimulation (Figures 5E and 5F). The release of these proteases from azurophilic granules was not blocked by NEi, indicating that oxidation promotes protease release by triggering NE dissociation from the complex without affecting the subsequent translocation across the membrane and without requiring NE activity during this step.
NE Regulates F-actin Dynamics during Translocation to the Nucleus
Interestingly, during NETosis in response to C. albicans, the neutrophils depolarized and rounded up ( Figure 6A ; Movie S1). The timing of this global and abrupt downregulation of actin dynamics immediately prior to nuclear decondensation prompted us to ask whether it was linked to NE release. We previously reported that blocking NE activity prevents the translocation of NE to the nucleus . To investigate NE localization in the presence of NEi, we isolated cytoplasm from activated neutrophils and cleared the granules and cytoskeleton by ultracentrifugation. We did not observe any soluble NE in the cytosol of activated neutrophils, suggesting that NE must be bound to an insoluble moiety ( Figure 6B ). Upon close examination of activated neutrophils, we observed that in the presence of NEi, NE failed to translocate to the nucleus, but localized in the cytoplasm away from azurophilic granules ( Figure 6A ). In contrast to untreated activated cells that appeared unpolarized, NEi-treated neutrophils remained polarized and continued to chemotax, indicating ongoing actin dynamics ( Figures 6C and 6D) . Strikingly, over time (2-3 hr), these neutrophils developed unusually large filopodia, where actin and NE colocalized ( Figure 6D ). This suggested that NE blocks actin dynamics and that inhibition of NE activity drives the accumulation of NE onto the actin cytoskeleton, preventing NE from reaching the nucleus. To test this hypothesis, we incubated purified NE with F-actin in the presence and absence of NEi and examined their association by an F-actin sedimentation assay. In the presence of NEi, purified NE bound to F-actin filaments in vitro and was sequestered to the actin pellet after cosedimentation occurred ( Figure 6E ). Strikingly, NE was present in the soluble fraction only in the absence of NEi, while some actin appeared degraded in the pellet. These data suggest that NE binds to F-actin in the cytoplasm and must degrade it in order to be free to translocate to the nucleus. Accordingly, in neutrophils undergoing NETosis in response to C. albicans, actin levels rapidly decreased by 30 min (the peak of NE translocation; Figure 6F ), but not in response to soluble LPS, a weak inducer of NETosis. These findings expose an additional role of the azurosome in regulating actin dynamics through the modulation of NE proteolytic activity. This mechanism of arresting chemotaxis may also serve to deploy NETs in the vicinity of pathogens.
DISCUSSION
Our data suggest that resting neutrophils contain a subset of azurophilic granules in which specific antimicrobial proteins localize on the membrane ( Figure 6G ). Upon neutrophil stimulation, the oxidative burst generates H 2 O 2 that triggers the activation and dissociation of NE, CG, and AZU from a complex that also contains MPO, LTF, PR3, and LYZ. We named this complex the ''azurosome'' because it was isolated from azurophilic granules. The detailed mechanism by which ROS promote dissociation remains unclear and may involve a reaction with MPO or other proteins of the complex. Importantly, MPO is required for the release of the proteases across intact membranes through a mechanism that remains to be elucidated. Once in the cytoplasm, NE binds the actin cytoskeleton and is sequestered in at the highest concentration. Fitting was used to calculate the concentration of azurosome required for 50% release (R 50 ) and the apparent cooperativity coefficient (n H ).
(B) Calcein release from synthetic liposomes incubated with control azurosome or purified MPO, monitored by fluorescence. The azurosome was quantified based on MPO content as measured by ELISA and expressed in moles (x axis). Fitting was used to calculate the concentration of azurosome required for 50% release (R 50 the insoluble fraction of the cytoplasm. The activation of NE by H 2 O 2 /MPO promotes F-actin degradation, liberating the protease to enter the nucleus. Interestingly, the dissociation of the azurosome proteases is regulated by oxidation. The subsequent translocation of these proteases across the membrane is also mediated by the azurosome, which can mediate the release of other granule and liposome cargo constitutively in vitro. Our results suggest that protease dissociation is an active process, whereas crossing the membrane occurs passively. Translocation across the membrane via the azurosome may be bidirectional, but release may be driven entropically by a concentration gradient from the granule, where the cargo is highly concentrated, toward the cytosol, where cargo concentration is low. Interactions with the actin cytoskeleton and chromatin on the other side of the granule membrane may enhance this process thermodynamically. The proteolytic activity of NE may allow it to be liberated slowly from F-actin and enter the nucleus progressively to process histones and accumulate by binding tightly to the DNA. Accordingly, we find that during translocation, only 20%-40% of NE is soluble, indicating a slow transient process that is also reflected by immunofluorescence microscopy.
The ability of the purified azurosome to release native granule proteins without additional stimulation in vitro poses an interesting problem, since it suggests that granule cargo would be free to leak into the cytosol in naive neutrophils. As this is likely not the case, additional regulatory mechanisms may exist in vivo to prevent unregulated release. Notably, under naive conditions, granule proteins are thought to be packed in a semisolid state that may immobilize these proteins inside the granule and prevent interactions with the azurosome and subsequent translocation. However, more work is needed to address these issues.
The ability of the complex to release calcein and granule proteins when added exogenously to synthetic and native granules without disrupting membrane integrity ( Figures 4A, 4C , and 4E) suggests that the azurosome incorporates into the lipid bilayer. The complex may assemble to form either a pore or protein transport machinery that transiently binds to cargo and rotates within the bilayer to release it on either side of the membrane. The cooperativity of the titration curve ( Figure 4A) indicates that multiple azurosome molecules must assemble for efficient release. Multimerization is encountered in various pore-forming proteins and ion channels (Anderluh and Lakey, 2010) , but it could also support a rotation model. Protein translocation across the membrane is dependent on MPO protein ( Figure 4A ), but not on MPO activity, as release of calcein and LYZ is greatly diminished in an MPO-deficient complex but is not affected by H 2 O 2 stimulation ( Figure 5C ). Therefore, MPO is a key component that allows transport of cargo across membranes. MPO has also been shown to regulate neutrophil signaling via other nonenzymatic mechanisms during its activation of macrophage-1 antigen (Mac-1) (El Kebir and Filep, 2013) .
Our experiments suggest that complex dissociation may not require the enzymatic activity of MPO either, since ABAH did not block dissociation and HOCl was not sufficient to promote it in vitro. However, these experiments should be considered with caution because ABAH does not completely block the generation of HOCl, and exogenously added HOCl may not be equivalent to the enzymatic product of MPO. Nevertheless, the enzymatic activity of MPO and its products play an important role in delivering NE to the nucleus, since the H 2 O 2 /MPO system activates the proteolytic activity of NE (Figure 2A ). Although ABAH does not prevent NET formation, it slows down the process , likely due to the delayed degradation of actin and histones. The azurosome-dependent protease activation highlights the importance of the complex as a protein scaffold that confers temporal and spatial specificity to oxidative signaling. ROS are highly reactive, short-lived molecules with low target specificity. The association of proteases with MPO allows the MPO/H 2 O 2 system to specifically target the proteases for activation. ROS are known to regulate a wide range of cellular processes (Nathan, 2003; Tonks, 2005; Winterbourn, 2008) and this paradigm may operate in other signaling pathways. Inflammatory monocytes express MPO and are implicated in cardiovascular disease (Sugiyama et al., 2001 ). MPO may form complexes similar to the azurosome in these cells to regulate a variety of processes.
Our data show that NE drives nuclear decondensation but is also important for the disassembly of the actin cytoskeleton. This step may serve to immobilize neutrophils and allow the precise deployment of NETs within the site of infection. Furthermore, the dismantling of the cytoskeleton may serve to facilitate the disruption of the cytoplasmic membrane that precedes NET release. The degradation of actin may serve to reduce dangerassociated actin signals during clearance of dying neutrophils by dendritic and scavenger cells (Ahrens et al., 2012) . In addition, NE may degrade other proteins in the cytoplasm to affect additional neutrophil functions and the interaction with scavenging macrophages that regulate the resolution of inflammation (Serhan and Savill, 2005) .
Our findings highlight the sophisticated architecture of neutrophil granules and suggest that distinct subsets of azurophilic granules may have different functions. Notably, azurosome-containing granules are not impermeable membrane compartments, but possess sophisticated machinery that mediates the selective, regulated release of granule cargo delivered through mechanisms that do not involve membrane fusion. The mechanism of NE release shares similarities with models that have been proposed to explain the release of cathepsins from intact lysosomes and the permeabilization of mitochondrial membranes during cell death (Boya and Kroemer, 2008) . Bcl-2 proteins assemble on mitochondrial membranes and form pores that allow the release of molecules larger than 100 kDa without membrane rupture. Although some reports claim that these Bcl-2 proteins assemble on lysosomal membranes during apoptosis, it is not clear whether lysosomal protease release involves a protein transporter, a pore-forming complex, or lysis of a lysosome subpopulation. Importantly, ROS are important mediators of lysosomal cathepsin release during necrosis, suggesting that it may share functional similarities with NE release during NETosis.
We found that the azurosome is important in NETosis, but not during phagocytosis. This distinct role may be exploited for treating human disease. Inhibitors of the azurosome could potentially lead to therapies that inhibit NET formation specifically without disrupting other neutrophil functions.
EXPERIMENTAL PROCEDURES
NET Formation
Human neutrophils were isolated from peripheral blood as previously described . We then seeded 5 3 10 4 neutrophils per well in 24-well tissue culture plates in 1 ml RPMI with 10 mM HEPES and 1% fetal calf serum (FCS). Cells were allowed to settle at 37 C for 1 hr in the presence of a pharmacological inhibitor, when indicated, before stimulation with 100 nM PMA (Sigma-Aldrich). NETs were formed 2-4 hr after PMA or C. albicans (multiplicity of infection [moi] = 10) stimulation.
Endogenous Histone Degradation in Activated Neutrophils
For each sample, three wells containing 2 3 10 5 neutrophils were seeded in six-well plates in 3 ml RPMI, 10 mM HEPES, 1% FCS (for naive cells or PMA). Cells were stimulated with 100 nM PMA or plasma-opsonized C. albicans (moi = 10). At the indicated time points, the medium was removed and the cells were resuspended in 400 ml 13 Laemmli SDS buffer.
Subcellular Fractionation Preparation of Neutrophil Lysates
For experiments measuring NE release into the cytosol, 8 3 10 6 neutrophils were seeded in 10 cm dishes in RPMI, 10 mM HEPES, and 1% FCS. They were allowed to settle for 30 min at 37 C in the absence or presence of 20 mM NEi (GW311616A; Sigma-Aldrich), 20 mM CG inhibitor (CGi, 219372; EMD), or 40 mg/ml PEG-catalase (C4963; Sigma-Aldrich), and then activated with 100 nM PMA. At the indicated time points, cells were scraped into 500 ml cold granule prep buffer (GPB) (20 mM HEPES pH 7.4, 100 mM KCl, 100 mM sucrose, 3 mM NaCl, 3 mM MgCl 2 , 1 mM EGTA). Naive cells were lysed by nitrogen cavitation at 400 psi for 2-3 min and the nuclei were removed by centrifugation at 300 3 g for 15 min to generate low-speed supernatant (LSS). The LSS was centrifuged at 100,000 3 g for 1 hr to yield high-speed supernatant (HSS).
Isolation of Granules
For granule preparations, LSS from 2-5 3 10 7 neutrophils/ml was centrifuged (37,000 3 g, 20 min) over a discontinuous (1.050, 1.090, and 1.120 g/ml) Percoll gradient as described previously (Kjeldsen et . MPO activity was measured with 0.1 mg/ml O-phenylenediamine (Sigma-Aldrich) in the presence of 500 mM H 2 O 2 .
Protease Activity Assays H4 Substrate LSS extracts from naive or PMA-activated neutrophils were incubated for 3 hr with 5 mg/ml histone H4 (New England Biolabs) in the absence or presence of 0.2% NP-40 and then resolved by SDS-PAGE and immunoblotting against histone H4. b-galactosidase Substrate Purified b-galactosidase (10 U/ml; Sigma-Aldrich) was added to granules (30 mg/ml total protein) and incubated for 6-16 hr. Where noted, reactions included 0.2% NP-40 (labeled as ''detergent''), 100 mM H 2 O 2 , 500 mM HOCl, 20 mM NEi, and/or 20 mM CGi. For colorimetric readout, 0.5 mg/ml X-gal (5-bromo-4-chloro-indolyl-b-D-galactopyranoside; Sigma-Aldrich) was added to the samples. For immunoblots, samples were dissolved in Laemmli SDS loading buffer. were incubated with 30 mg/ml rabbit anti-NE antibody (ab21595; Abcam) or mock antibody (rabbit anti-MMP9, A0150 [Dako] or rabbit anti-BPI, B2188
Azurosome Work
[Sigma]) for 2 hr at 4 C. Aliquots of total reactions were removed prior to antibody addition. Protein-G Ultralink resin (Pierce) slurry (10-15 ml) was then added and incubated for 2 hr. Beads were rinsed three times in 1 ml GPB, three times in 1 ml GPB + 0.5 U/ml heparin to remove nonspecific ionic binding ( Figure S2D ), and then three times in 1 ml GPB. Bound proteins were eluted with 50 ml of 0.1 M glycine (pH 2.7) and then 10 ml of 1 M HEPES (pH 7.4) was added to neutralize the pH. Then 63 Laemmli sample buffer was added. Elutions and total reactions were boiled and analyzed by SDS-PAGE electrophoresis and Coomassie staining or immunoblotting. Complex Purification AZ granules, unactivated or preactivated with 100 mM H 2 O 2 for 2 hr at 37 C, were permeabilized with 0.1% NP-40. Then 2 ml of sample was loaded onto a Superdex 200 GL column and eluted with 20 mM HEPES pH 7.4, 100 mM NaCl, plus 0.5 U/ml heparin to prevent nonspecific ionic binding ( Figure S2D ). For functional experiments, fractions containing the azurosome (usually 18-28) were combined and concentrated over Amicon Ultracell 3k filters to approximately 5-10 mg/ml total protein concentration.
Protein Release
Release from Liposomes Calcein-loaded liposomes were diluted into 200 ml osmo-PBS at 100 mM final total lipid concentration in the presence or absence of the indicated protein or azurosome concentrations. Where indicated, purified MPO (0.1-1 mM), 100 mM H 2 O 2 , or 10 mM NEi was added to the reactions. Samples were left to incubate for 10 min at 25 C and calcein fluorescence was recorded. Duplicate and triplicate samples were used for error calculation. After each read, 0.1% Triton X-100 was added to each sample to obtain the 100% permeabilization values. Data were normalized to the liposomes alone (lower limit) and liposomes in the presence of Triton (maximum) measurements.
Release from Granules
For release from granules, 15 mg of a mixture of specific and gelatinase granules, isolated as described above, was incubated with azurosome containing the equivalent of 50 nM NE (as measured by ELISA and semiquantitative immunoblot) in the absence or presence of 1% NP-40 for 1.5 hr at 37 C.
An aliquot of the total reaction (T) was removed and reactions were centrifuged at 100,000 3 g for 1 hr to yield the soluble fraction (S). Equivalent volumes of S and T fractions were dissolved in 13 Laemmli SDS loading buffer. The amount of LYZ or LTF in the azurosome alone control lanes was subtracted from the experimental lanes. The amount of LYZ or LTF in each soluble fraction was normalized to the total amount in the granules-alone sample. Azurophilic Granule-Antibody Interaction Rabbit anti-MPO and rabbit anti-BPI (0.5 mg) were mixed with freshly prepared azurophilic granules containing 30 mg total protein in 100 ml and incubated 30 min on ice. Reactions were overlaid over a 1.05, 1.09, and 1.12 mg/ml discontinuous Percoll gradient in 13 GPB and centrifuged at 37,000 3 g for 20 min. The soluble supernatant was collected, upper Percoll layers were aspirated, and the 1.09/1.12 interface containing sedimented azurophilic granules was isolated. Then 5 ml of the soluble supernatant and 30 ml of the azurophilic fraction were analyzed by SDS-PAGE electrophoresis followed by western immunoblotting with a horseradish peroxidase-conjugated anti-rabbit immunoglobulin G (IgG) antibody. Proteinase K Protection Assay LSS or azurophilic granules prepared by nitrogen cavitation of 4 3 10 6 neutrophils/ml in GPB were left untreated or pretreated with 0.2% Triton X-100 for 5 min at 37 C, and then left untreated or treated with 1-100 mg/ml proteinase K (Sigma-Aldrich) for 30 min at 37 C. After the reactions, 1 mM PMSF was added to inhibit proteinase K.
Degradation of S. flexneri IpaB by Neutrophils
S. flexneri M90T were cultured with 4.5 3 10 6 neutrophils in RPMI-HEPES (moi = 30) in the absence or presence of 20 mM NEi and/or 500 mM of the MPO inhibitor ABAH. At 15 min postinfection, the medium was removed and cells were washed three times. At 90 min postinfection, the medium was removed and samples were lysed into 400 ml Laemmli SDS loading buffer.
Assessment of Granule Integrity Using the CASY Impedance Cell Counter
To assess granule integrity, 55 mg of azurophilic granules in 25 ml GPB, or 5 mg of PC/PS liposomes in 200 ml buffer was either left untreated or treated with 100 mM H 2 O 2 , 10 mg/ml purified azurosome, or 0.2%-0.5% NP-40 for 90 min at 37 C. Thereafter, reactions were diluted into PBS and impedance was measured using a CASY cell counter equipped with a 45 mM capillary. Azurocidin Release Azurophilic granules (50 mg total protein) were preincubated in the absence or presence of 20 mM NEi on ice for 30 min. H 2 O 2 (100 mM) was added to 300 ml reactions and incubated for 30 min at 37 C. Then 50 ml of the reaction was removed for the total and the remaining reaction was centrifuged over a 1.050 g/ml Percoll layer at 37,000 3 g for 20 min to remove granules and collect 50 ml of supernatant.
NE Release
Azurophilic granules in the presence of 10 mM NEi or vehicle (DMSO) were placed in human NE ELISA wells (Hycult Biotech) and stimulated with 100 mM H 2 O 2 or 100 and 500 mM HOCl for 30 min at 37 C in GPB. Duplicate samples were used. For total samples, NP-40 was added prior to stimulation. Supernatants were removed, wells were washed with ELISA wash buffer, and NE protein released was detected with the ELISA kit.
F-actin Cosedimentation Assays
For F-actin cosedimentation assays, 0.5 mg/ml G-actin from rabbit muscle was polymerized for 1 hr at room temperature in 200 ml of 5 mM Tris-HCl pH 8.2, 50 mM KCl, 0.2 mM CaCl 2 , 1.2 mM ATP, 2 mM MgCl 2 , 0.5 mM dithiothreitol. Then 100 ml containing 0.3 mg/ml NE was centrifuged at 100,000 3 g for 20 min at 4 C to remove aggregates. NEi was added to the supernatant where indicated and mixed with 200 ml polymerized actin, yielding a final NE concentration of 0.1 mg/ml. Reactions were incubated for 30 min at 37 C and centrifuged at 100,000 3 g for 20 min at room temperature. The supernatant was carefully removed and the pellet was resuspended in 300 ml buffer. Live-Cell Microscopy Neutrophils were incubated with heat-inactivated C. albicans (moi = 50) in the presence of Sytox Green and imaged every 30 s for 4 hr by confocal microscopy (six frames per second). (A) Nuclear decondensation after treatment of isolated HL-60 nuclei with buffer or cytoplasmic extract (LSS) for the indicated durations, in the absence (white circles) or presence (black circles) of H 2 O 2 . Cytoplasmic extract was made by nitrogen cavitation, without detergent, to keep granule membranes intact. Nuclear decondensation was assessed by measuring Sytoxstained DNA areas from micrographs using ImageJ. ***: P<0.001, ANOVA: P<0.0001 analysis for the indicated group of samples. (B) Degradation of β-galactosidase (β-gal) by azurophilic granules from control and ΔMPO neutrophils. The same samples from Figure 2A were assessed by immunoblotting against β-gal. Where indicated, H 2 O 2 and/or NP-40 (det) were added to the reactions. (C) β-gal activity against X-gal after incubation with azurophilic granules in the absence or presence of H2O2. Where indicated, granules were pre-incubated with NEi, CGi or both inhibitors. ***: P<0.001 between the indicated samples. Untreated azurophilic granules were lysed with NP--40 and the soluble contents were purified over a Superdex 200 GL column. Pre--treated granules were stimulated for 120 min with H2O2, solubilized and passed over the column. Post--treated proteins were first purified by size exclusion chromatography from untreated granules and then were subsequently stimulated with H2O2 ( Figure  6B ). (F) Protease activity against β--galactosidase of purified azurosome (same fractions as in Figure 2E ), either untreated or post--treated with H2O2 (see cartoon in Figure S3A ). Increase in proteolytic activity is plotted as a reduction in β--galactosidase activity, expressed as an increase in the T1/2 of the enzymatic kinetic curve against X--gal. Time--lapse of live cell microscopy depicting neutrophils depolarizing while forming NETs in response to C. albicans (MOI=50) in the presence of the cell impermeable dye Sytox Green that stains DNA in permeabilized neutrophils. Phase contrast and Sytox fluorescent images were obtained every 30 sec for 4 hrs by confocal microscopy. The movie was made at 6 frames per second.
Complete Experimental Procedures Donors
All donors gave consent to blood drawing in accordance with the Declaration of Helsinki. Samples were collected with approval from the ethical committees at each institution. The ∆MPO donor bears a homozygous splice mutation (c.2031--2A>C/c.2031--2A>C, nomenclature according to (den Dunnen and Antonarakis, 2001 )) (Mauch et al., 2007) , which generates null alleles. Lack of mature MPO protein and MPO activity was confirmed in .
NET formation
Human neutrophils were isolated from peripheral blood as previously described . 5 × 10 4 neutrophils were seeded per well in 24--well tissue culture plates, in 1 ml RPMI with 10 mM HEPES and 1% FCS. Cells were allowed to settle at 37°C for 1h, in the presence of pharmacological inhibitor when indicated, before stimulation with 100 nM phorbol 12--myristate 13--acetate (PMA; Sigma--Aldrich). NETs were formed 2--4h after PMA stimulation.
Wild type Candida albicans was grown overnight at 30°C in YPD medium,
which favors the yeast form of the organism. C. albicans were resuspended at 10x the desired multiplicity of infection (MOI=10) in 100% human plasma (obtained by centrifuging blood over Histopaque 1119 and collecting the upper layer) and incubated for 1h at room temperature. The mixture was diluted 1:10 into experimental sample wells and centrifuged for 5 min at 700 x g to synchronize the infection. NETs were formed within 2--4h after C. albicans stimulation.
Antibodies
Immunofluorescence staining
Neutrophils were fixed on glass coverslips using 2% paraformaldehyde 
Endogenous histone degradation in activated neutrophils
For each sample, 3 wells containing 2 x 10 5 neutrophils each were seeded in 6--well plates, in 3 ml RPMI with 10 mM HEPES and 1% FCS (for naïve cells or when PMA was to be added), or without FCS but 3% human plasma for C.
albicans experiments. Cells were allowed to settle at 37˚C for 1h in the absence or presence of any inhibitors, before stimulation with 100 nM PMA or plasma--opsonized C. albicans at an MOI of 10. At the indicated time points, medium was removed and cells were resuspended in 400 µl total of 1X Laemmli SDS buffer, then samples were processed for immunoblotting against histone H4.
Subcellular fractionation
Preparation of neutrophil lysates
For experiments measuring NE release into cytosol, lysates were made from naïve or PMA--activated neutrophils from control or ∆MPO donors during a 2h timecourse. 8 x 10 6 neutrophils were seeded in 10 cm dishes in RPMI with 10 mM HEPES and 1% FCS, allowed to settle for 30 min at 37ºC in the absence or presence of 20 μM NE inhibitor (NEi, GW311616A, Sigma--Aldrich), 20 μM CG inhibitor (CGi, 219372, EMD), or 40 ug/ml PEG--catalase (C4963, Sigma--Aldrich), which can be taken up by endocytosis (Beckman et al., 1988) , and activated with 100 nM PMA. At the indicated time points, cells were scraped into 500 μl cold granule prep buffer (GPB) (20 mM HEPES pH 7.4, 100 mM KCl, 100 mM sucrose, 3 mM NaCl, 3 mM MgCl2, 1 mM EGTA). Naïve cells were lysed using nitrogen cavitation at 400 psi for 2--3 min (Udby and Borregaard, 2007) on ice; nuclei were removed by centrifugation at 300 x g for 15 min to generate LSS. LSS was centrifuged at 100,000 x g for 1h to yield high--speed supernatant. Measurements were taken in duplicates or triplicates and experiments were repeated 2--5 times.
Isolation of granules
For granule preparations, LSS from 2--5 x 10 7 neutrophils/ml was centrifuged (37,000 x g, 20 min) over a discontinuous (1.050, 1.090, and 1.120 g/ml) Percoll gradient as described previously .
Enzymatic assays
NE was quantitated using an ELISA kit (Hycult Biotechnology) according to the manufacturer's directions, or enzymatically by incubation with 300 mM Elastase Substrate I (MeOSuc--Ala--Ala--Pro--Val--pNA, Calbiochem) at 37°C and measuring endpoint absorbance at 410 nm. Concentrations of hydrogen peroxide (H2O2) and hypochlorous acid (HOCl) were measured as described in . MPO activity was measured with 0.1 mg/ml O--phenylenediamine (Sigma--Aldrich) in the presence of 500 μM H2O2 at 25˚C; absorbance was monitored at 450 nm.
Protease activity assays
H4 substrate
LSS extracts from naïve or PMA--activated neutrophils were incubated for 3h with 5 µg/ml histone H4 (New England Biolabs) in the absence or presence of 0.2% NP--40, then resolved by SDS--PAGE and immunoblotting against histone H4.
β --galactosidase substrate
Purified β--galactosidase (β--gal, Sigma--Aldrich) (10 U/ml) was added to samples containing proteases in 96--well plates. Granules were used at 30 μg/ml total protein. Reactions were incubated for 6--16h, depending on the protease concentration, to allow proteases to degrade β--gal. Where noted, reactions included 0.2% NP--40 (labeled as "detergent"), 100 μM H2O2, 500 μM HOCl, 20 μM
NEi and/or 20 μM CGi. For colorimetric readout, 0.5 mg/ml X--gal (5--bromo--4--chloro--indolyl--β--D--galactopyranoside, Sigma--Aldrich) was added to the samples and incubated for 30 min to 1h to develop blue color; absorbance was measured at 635 nm. Samples were measured in triplicate. For immunoblot readout, samples were dissolved in Laemmli SDS loading buffer, then processed for immunoblotting using an antibody against β --galactosidase. Figure 2D) Heparin at 0.5 U/mL was used in washes in immunoprecipitation experiments and gel filtration to prevent non--specific ionic interactions of basic proteins with resins. This is a traditional approach used routinely in biochemical work with highly basic proteins. To evaluate the effectiveness of heparin in our system, purified 5 μM MPO alone or pre--incubated with 0.5 μg polyclonal rabbit anti--MPO (Dako A0398) was incubated with Protein--G Ultralink resin (Pierce) in PBS. Beads were washed 3X with PBS alone or in the presence of 0.5 U/mL heparin, followed by 3X with PBS alone. Beads were tested for MPO activity after 10 min incubation with 0.1 mg/ml O--phenylenediamine (Sigma--Aldrich) and 100 μM H2O2 and normalized to the activity of the initial amount of MPO added in the experiment.
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Evaluating non--specific binding to resins (Supplemental
Immunoprecipitation experiments
Azurophilic granules or LSS in GPB were left untreated or treated with 100 μΜ H2O2 for 2h at 37°C. or rabbit anti--BPI, Sigma, B2188) for 2h at 4ºC. Aliquots of total reactions were removed prior to antibody addition.
10--15 μL of Protein--G Ultralink resin (Pierce) slurry was added and incubated for 2h. Beads were rinsed 3 times in 1 mL GPB, 3 times in 1 mL GPB + 0.5 U/mL heparin, then 3 times in 1 mL GPB. Bound proteins were eluted with 50 μL 0.1 M glycine pH 2.7, then 10 µl 1M HEPES pH 7.4 was added to neutralize the pH. 6X Laemmli sample buffer was added; elutions and total reactions were boiled and analyzed by SDS--PAGE electrophoresis and Coomassie staining or immunoblotting.
The physiological concentration of H2O2 at the peak of the respiratory burst is difficult to measure. Theoretical calculations place it in the micromolar range. However, this is a continuous and sustained burst. We used 100 μM H2O2 in our in vitro experiments, to ensure that enough of the oxidant is present to saturate the system, but not at concentrations that would far exceed the theoretical physiological estimates. The levels of H2O2 used were in equivalent ranges to concentrations used in studies modeling metabolic oxidation (Anastasiou et al., 2011) .
Complex purification
AZ granules, unactivated or pre--activated with 100 μM H2O2 for 2h at 37˚C, were permeabilized with 0.1% NP--40. 2 ml of sample was loaded onto a Superdex 200 GL column and eluted with 20 mM HEPES pH 7.4, 100 mM NaCl, plus 0.5 U/mL heparin to prevent non--specific ionic binding to the resin. For functional experiments, fractions containing the azurosome (usually 18--28) were combined and concentrated over Amicon Ultracell 3k filters to approximately 5--10 mg/mL total protein concentration.
Protein identification
Proteins were identified after in--gel tryptic digestions of excised bands as described in (Zimny--Arndt et al., 2009 ).
Protein release experiments
Preparation of calcein--filled synthetic liposomes
Phosphatidyl choline (egg yolk) and dipalmitoyl phosphatidyl--L--serine (brain) were purchased from Avanti Lipids. Large unilamellar PC:PS vesicles loaded with calcein were made by mixing lipids at a 4:1 molar ratio in chloroform, evaporating the chloroform over argon and rehydrating with PBS containing 50 mM calcein. Lipids were subjected to 10 rounds of flash freezing and thawing, followed by 1 min bath sonication. The liposomes were then centrifuged 1h at 100,000 x g, the supernatant was decanted and the pellet was reconstituted in PBS adjusted to 0.399 osmolarity with NaCl (osmo--PBS). This procedure was repeated 2 more times. Liposomes were resuspended in 200 μl osmo--PBS and extruded with a 0.4 μm filter.
Release from liposomes
This assay is based on the release of calcein stored at high concentration 
Release from granules
15 μg of a mixture of specific and gelatinase granules, isolated as described above, was incubated with azurosome containing the equivalent of 50 nM NE (as measured by ELISA and semi--quantitative immunoblot), in the absence or presence of 1% NP--40 for 1.5h at 37°C. An aliquot of total reaction (T) was removed and reactions were centrifuged at 100,000 x g for 1h to yield soluble fraction (S). Equivalent volumes of S and T fractions were dissolved in 1X
Laemmli SDS loading buffer and resolved by SDS--PAGE, then analyzed by immunoblotting against LYZ or LTF.
Bands were quantified using the densitometry function in ImageJ. The amount of LYZ or LTF in the azurosome alone control lanes was subtracted from the experimental lanes. The amount of LYZ or LTF in each soluble fraction was normalized to the total amount in the granules alone sample.
Azurophilic granule--antibody interaction
Rabbit anti--MPO and rabbit anti--BPI (0.5 μg) was mixed with freshly prepared azurophilic granules containing 30 μg total protein in 100 μL and incubated 30 min on ice. Reactions were overlayed over a 1.05, 1.09 and 1.12 mg/mL discontinuous Percoll gradient in 1X granule prep buffer, and centrifuged at 37,000 x g, 20 min. The soluble supernatant was collected, upper Percol layers were aspirated and the 1.09 / 1.12 interface containing sedimented azurophilic granules was isolated. 5 μL of the soluble supernatant and 30 μL of the azurophilic fraction were analysed by SDS--PAGE electrophoresis followed by western immunoblotting with an HRP--conjugated anti--rabbit IgG antibody.
Proteinase K protection assay LSS or azurophilic granules prepared by nitrogen cavitation of 4 x 10 6 neutrophils/ml in GPB was left untreated or pre--treated with 0.2% Triton X--100
for 5 min at 37˚C, then left untreated or treated with 1--100 µg/ml proteinase K (Sigma--Aldrich) for 30 min at 37˚C. After the reactions, 1 mM PMSF was added to inhibit proteinase K. Samples were dissolved in Laemmli SDS loading buffer and resolved by SDS--PAGE and immunoblotting against MPO and azurocidin.
Cryo--immunogold electron microscopy
For this analysis, 2 x 10 6 neutrophils were seeded per well in 6--well plates, in RPMI--HEPES with 1% FCS. At the indicated time points, cells were fixed with pre--warmed 2% PFA in PBS for 30 min at room temperature. The cells were harvested, gelatin--embedded and infiltrated with 2.3 M sucrose according to the method described (Peters PJ, 2006) . Ultrathin sections were cut at --120°C with a RMC MTX/CRX cryo--ultramicrotome (Boeckeler Instruments Inc.), transferred to carbon--and pioloform--coated EM--grids and blocked with 1% bovine serum albumin, 0.02 M glycine and 10% cold water fish gelatin in PBS. The sections were incubated with appropriate dilutions in the same buffer of mouse monoclonal antibody directed against NE (NP57, Dako A/S Denmark) and rabbit polyclonal antibody directed against MPO (A0398, Dako A/S Denmark).
Secondary antibody incubations were carried out with goat--anti--rabbit and goat--anti--mouse antibodies coupled to 12 nm and 6 nm gold particles (Jackson).
Specimens were then contrasted and embedded with uranyl--acetate/methyl--cellulose following the method described (Slot et al., 1991) and analyzed in a Leo 912AB or LEO 906 transmission electron microscope (Zeiss, Oberkochen, Germany) using a Cantega or Morada digital camera (Olympus Soft Imaging Solutions).
In vitro nuclear decondensation assays
As described in . Briefly, low speed supernatant extracts containing soluble cytosolic proteins and granules were prepared from 5 × 10 7 neutrophils/ml, lysed by Nitrogen cavitation in GPB and 0.1 mM PMSF.
Nuclei were removed by centrifugation at 300 g for 10 min. Intact HL60 nuclei were prepared from HL--60 cells differentiated with 5 μM retinoic acid for 96 h and isolated as described by Celis (1998) . Reactions were performed by mixing 10μl of neutrophil extract at 0.8 mg/ml total protein, with 10 4 nuclei and Sytox.
3--μl aliquots were transferred onto 12--well, 5--mm diagnostic slides (Menzel--Glaser) and covered with 20 × 50 mm coverslips. Reactions were performed in a humidified chamber at 37°C for the indicated timepoints in the absence or in the presence of 100μM H2O2. Decondensation of Sytox--labeled nuclei was documented by fluorescence microscopy and the area of each nucleus was calculated using ImageJ software.
Degradation of S. flexneri IpaB by neutrophils
Shigella flexneri M90T were cultured overnight at 37°C in TSB and Assessment of granule integrity using CASY impedance cell counter 55 µg of azurophilic granules in 25 µl GPB, or 5 µg of PC/PS liposomes in 200 µl buffer, were either left untreated or treated with 100 μM H2O2, 10 µg/ml purified azurosome or 0.2--0.5% NP--40 for 90 min at 37˚C. Thereafter, reactions were diluted into PBS and impedance was measured using a CASY cell counter equipped with a 45 µM capillary.
Azurocidin release
Azurophilic granules (50 μg total protein) were pre--incubated in the absence or presence of 20 μM NEi on ice for 30 min. 100 μM H2O2 was added to 300 μL reactions and incubated for 30 min at 37˚C. 50 μL of the reaction were removed for the total and the remaing was centrifuged over a 1.050 g/mL Percoll layer at 37,000 x g, 20 min to remove granules and collect 50 μL of supernatant.
NE release
Azurophilic granules in the presence of 10 μΜ NEi, or vehicle (DMSO) were placed in human NE ELISA wells (Hycult Biotech) and stimulated with 100 μΜ H2O2 or 100 and 500 μΜ HOCl for 30 min at 37˚C in granule prep buffer.
Duplicate samples were used. For total samples, NP--40 was added prior to stimulation. Supernatants were removed, wells were washed with ELISA wash buffer and NE protein released was detected with the ELISA kit.
F--Actin co--sedimentation assays
0.5 mg/mL G--actin from rabbit muscle was polymerized for 1 hr at RT in 200μL of 5 mM Tris--HCl pH 8.2, 50mM KCl, 0.2 mM CaCl2, 1.2 mM ATP, 2 mM MgCl2, 0.5 mM DTT. 100μL containing 0.3 mg/mL NE was centrifuged at 100,000
x g for 20 min at 4˚C to remove aggregates. NEi was added to supernatant where indicated and mixed with 200 μL polymerized actin yielding a final NE concentration of 0.1 mg/mL. Reactions were incubated for 30 min at 37˚C and centrifuged at 100,000 x g, 20 min, RT. The supernatant was carefully removed and the pellet was resuspended in 300 μL buffer.
Live cell microscopy
Neutrophils were incubated with heat--inactivated C. albicans (MOI=50) in the presence of the cell impermeable dye Sytox Green that stains DNA in permeabilized neutrophils. Phase contrast and Sytox fluorescent images were obtained every 30 sec for 4 hrs by confocal microscopy. The movie was made at 6 frames per second.
Statistical analysis
All experiments were repeated 2--5 times and representative results are shown. In Figure S2A , raw measurements were analyzed in GraphPad Prism 5 software using the Kruskal--Wallis analysis of variance and Dunn multiple comparison test. All other measurements were analyzed in Microsoft Excel by unpaired T--test.
